EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Emerging Forms of Regulated Cell Death Modalities Associated with Immunogenic Cell Death and Their Translational Potential in Cancer Immunotherapy

Ruijie Xu

Transactions on Materials, Biotechnology and Life Sciences · 23.09.2026 · 10 · 32-41

DOI: 10.62051/ryr2zs48 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transactions on Materials, Biotechnology and Life Sciences, online erschienen am 23.09.2026. Verfasst von Ruijie Xu. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor immunotherapy has demonstrated significant clinical value in various malignancies by activating the host antitumor immune response. However, its clinical benefits are still limited by factors such as insufficient tumor immunogenicity, an immunosuppressive tumor microenvironment (TME), and acquired drug resistance. Inducing immunogenic cell death (ICD) in tumor cells can promote the release of tumor antigens, the exposure of danger signals, and antigen presentation, thereby facilitating the conversion of certain “cold” tumors into “hot” tumors and enhancing the response to immunotherapy. In recent years, the relationship between regulated cell death (RCD) and ICD has received widespread attention. Nevertheless, not all forms of RCD possess equivalent immunogenicity; different RCD modalities exhibit varying degrees of potential to induce ICD, remodel the tumor immune microenvironment, and synergize with immune checkpoint inhibitor (ICI) therapy. This review focuses on several RCD types that have been actively researched in recent years and show clear associations with ICD—including ferroptosis, pyroptosis, necroptosis, cuproptosis, and disulfidptosis—summarizing their mechanistic links to ICD, their roles in immune regulation, and their translational prospects in tumor immunotherapy. It further discusses the current challenges in the field and future research directions.

Zitieren

APA

Xu, R. (2026). Emerging Forms of Regulated Cell Death Modalities Associated with Immunogenic Cell Death and Their Translational Potential in Cancer Immunotherapy. Transactions on Materials, Biotechnology and Life Sciences, 10, 32-41. https://doi.org/10.62051/ryr2zs48

Vancouver

Xu R. Emerging Forms of Regulated Cell Death Modalities Associated with Immunogenic Cell Death and Their Translational Potential in Cancer Immunotherapy. Transactions on Materials, Biotechnology and Life Sciences. 2026;10:32-41. doi:10.62051/ryr2zs48

BibTeX
@article{Xu2026,
  author = {Xu, Ruijie},
  title = {Emerging Forms of Regulated Cell Death Modalities Associated with Immunogenic Cell Death and Their Translational Potential in Cancer Immunotherapy},
  journal = {Transactions on Materials, Biotechnology and Life Sciences},
  year = {2026},
  volume = {10},
  pages = {32--41},
  doi = {10.62051/ryr2zs48}
}
Kostenlos starten →